These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
199 related items for PubMed ID: 8338721
1. In vitro and in vivo irreversible plasma protein binding of beclobric acid enantiomers. Mayer S, Mutschler E, Benet LZ, Sphahn-Langguth H. Chirality; 1993; 5(3):120-5. PubMed ID: 8338721 [Abstract] [Full Text] [Related]
2. Pharmacokinetics of beclobric acid enantiomers and their conjugates after single and multiple oral dosage of racemic beclobrate. Mayer S, Spahn-Langguth H, Gikalov I, Mutschler E. Arzneimittelforschung; 1993 Jan; 43(1):40-3. PubMed ID: 8447845 [Abstract] [Full Text] [Related]
4. Pharmacokinetic studies with the lipid-regulating agent beclobrate: enantiospecific assay for beclobric acid using a new fluorescent chiral coupling component (S-FLOPA). Mayer S, Mutschler E, Spahn-Langguth H. Chirality; 1991 Jan; 3(1):35-42. PubMed ID: 2039683 [Abstract] [Full Text] [Related]
5. Interaction of human serum albumin with the electrophilic metabolite 1-O-gemfibrozil-beta-D-glucuronide. Sallustio BC, Fairchild BA, Pannall PR. Drug Metab Dispos; 1997 Jan; 25(1):55-60. PubMed ID: 9010630 [Abstract] [Full Text] [Related]
7. Chemical and immunochemical comparison of protein adduct formation of four carboxylate drugs in rat liver and plasma. Bailey MJ, Dickinson RG. Chem Res Toxicol; 1996 Jan; 9(3):659-66. PubMed ID: 8728513 [Abstract] [Full Text] [Related]
8. Reactivity of mefenamic acid 1-o-acyl glucuronide with proteins in vitro and ex vivo. McGurk KA, Remmel RP, Hosagrahara VP, Tosh D, Burchell B. Drug Metab Dispos; 1996 Aug; 24(8):842-9. PubMed ID: 8869817 [Abstract] [Full Text] [Related]
9. [Pharmacokinetics and bioequivalence of two peroral beclobrate preparations]. Gikalov I, Ifflaender U. Arzneimittelforschung; 1987 Sep; 37(9):1065-8. PubMed ID: 3435603 [Abstract] [Full Text] [Related]
10. In vitro irreversible binding of ketoprofen glucuronide to plasma proteins. Dubois N, Lapicque F, Maurice MH, Pritchard M, Fournel-Gigleux S, Magdalou J, Abiteboul M, Siest G, Netter P. Drug Metab Dispos; 1993 Sep; 21(4):617-23. PubMed ID: 8104120 [Abstract] [Full Text] [Related]
13. Irreversible binding of zomepirac to plasma protein in vitro and in vivo. Smith PC, McDonagh AF, Benet LZ. J Clin Invest; 1986 Mar; 77(3):934-9. PubMed ID: 3949982 [Abstract] [Full Text] [Related]
15. Stereoselective irreversible binding of ketoprofen glucuronides to albumin. Characterization of the site and the mechanism. Presle N, Lapicque F, Fournel-Gigleux S, Magdalou J, Netter P. Drug Metab Dispos; 1996 Oct; 24(10):1050-7. PubMed ID: 8894504 [Abstract] [Full Text] [Related]
17. Conjugation of the enantiomers of ketotifen to four isomeric quaternary ammonium glucuronides in humans in vivo and in liver microsomes. Mey U, Wachsmuth H, Breyer-Pfaff U. Drug Metab Dispos; 1999 Nov; 27(11):1281-92. PubMed ID: 10534313 [Abstract] [Full Text] [Related]
18. Reactivity of gemfibrozil 1-o-beta-acyl glucuronide. Pharmacokinetics of covalently bound gemfibrozil-protein adducts in rats. Sallustio BC, Foster DJ. Drug Metab Dispos; 1995 Sep; 23(9):892-9. PubMed ID: 8565777 [Abstract] [Full Text] [Related]